Cargando…

Intrathecal CD8(+)CD20(+) T Cells in Primary Progressive Multiple Sclerosis

BACKGROUND AND OBJECTIVE: Despite accumulating evidence of intrathecal inflammation in patients with primary progressive multiple sclerosis (PPMS), immunomodulatory and suppressive treatment strategies have proven unsuccessful. With this study, we investigated the involvement of CD20(+) T cells and...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Essen, Marina Rode, Talbot, Jacob, Hansen, Rikke Holm Holm, Chow, Helene Højsgaard, Lundell, Henrik, Siebner, Hartwig Roman, Sellebjerg, Finn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299852/ https://www.ncbi.nlm.nih.gov/pubmed/37369602 http://dx.doi.org/10.1212/NXI.0000000000200140

Ejemplares similares

Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis
por: Holm Hansen, Rikke, et al.
Publicado: (2022)

Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial
por: Højsgaard Chow, Helene, et al.
Publicado: (2021)

Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control
por: von Essen, Marina Rode, et al.
Publicado: (2023)

Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis
por: von Essen, Marina Rode, et al.
Publicado: (2022)

IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8(+) T Cells
por: Buhelt, Sophie, et al.
Publicado: (2021)

Disentangling white-matter damage from physiological fibre orientation dispersion in multiple sclerosis
por: Andersen, Kasper Winther, et al.
Publicado: (2020)

Progressive multiple sclerosis, cognitive function, and quality of life
por: Højsgaard Chow, Helene, et al.
Publicado: (2018)

Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls
por: Buhelt, Sophie, et al.
Publicado: (2019)

Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study
por: Madsen, Mads A J, et al.
Publicado: (2022)

Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis
por: Börnsen, Lars, et al.
Publicado: (2012)

Mapping grip-force related brain activity after a fatiguing motor task in multiple sclerosis
por: Svolgaard, Olivia, et al.
Publicado: (2022)

Imaging cortical multiple sclerosis lesions with ultra-high field MRI
por: Madsen, Mads A.J., et al.
Publicado: (2021)

Motor fatigue is associated with asymmetric connectivity properties of the corticospinal tract in multiple sclerosis
por: Bauer, Christian, et al.
Publicado: (2020)

Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis
por: Lund, Henrik, et al.
Publicado: (2013)

Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis
por: Dogonowski, Anne-Marie, et al.
Publicado: (2016)

IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis
por: von Essen, Marina R., et al.
Publicado: (2019)

Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis
por: Filikci, Zuhal, et al.
Publicado: (2022)

Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity
por: Lehmann-Horn, Klaus, et al.
Publicado: (2014)

Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
por: Weber, Martin S.
Publicado: (2015)

White matter diffusivity and its correlations to state measures of psychopathology in male refugees with posttraumatic stress disorder
por: Wiingaard Uldall, Sigurd, et al.
Publicado: (2021)

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
por: de Sèze, Jérôme, et al.
Publicado: (2023)

Socioeconomic status of the elderly MS population compared to the general population: a nationwide Danish matched cross-sectional study
por: Wandall-Holm, Malthe Faurschou, et al.
Publicado: (2023)

Activated human CD4(+) T cells express transporters for both cysteine and cystine
por: Levring, Trine Bøegh, et al.
Publicado: (2012)

Pulsed immune reconstitution therapy in multiple sclerosis
por: Sorensen, Per Soelberg, et al.
Publicado: (2019)

Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018)

Cerebellar and premotor activity during a non-fatiguing grip task reflects motor fatigue in relapsing-remitting multiple sclerosis
por: Svolgaard, Olivia, et al.
Publicado: (2018)

Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis
por: Sabatino, Joseph J., et al.
Publicado: (2019)

Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
por: Florou, Despoina, et al.
Publicado: (2020)

Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab
por: Gingele, Stefan, et al.
Publicado: (2019)

Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
por: Roach, Charles A., et al.
Publicado: (2021)

Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
por: Heming, Michael, et al.
Publicado: (2023)

The intrathecal CD163-haptoglobin–hemoglobin scavenging system in subarachnoid hemorrhage
por: Galea, James, et al.
Publicado: (2012)

An open-source tool for longitudinal whole-brain and white matter lesion segmentation
por: Cerri, Stefano, et al.
Publicado: (2023)

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
por: Shinoda, Koji, et al.
Publicado: (2023)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021)

Variation in NOD2 Augments Th2- and Th17 Responses to Myelin Basic Protein in Multiple Sclerosis
por: Hedegaard, Chris Juul, et al.
Publicado: (2011)

Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis()
por: Novak, Frederik, et al.
Publicado: (2021)

Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Christensen, Jeppe Romme, et al.
Publicado: (2013)

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Romme Christensen, Jeppe, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nn636lb1jonrtqruo44lhg6iqa